Sopharma AD (BUL:SFA)
5.78
0.00 (0.00%)
At close: Apr 17, 2025
Sopharma AD Revenue
In the year 2024, Sopharma AD had annual revenue of 2.14B BGN with 13.27% growth. Sopharma AD had revenue of 587.96M in the quarter ending December 31, 2024, with 16.63% growth.
Revenue
2.14B
Revenue Growth
+13.27%
P/S Ratio
0.45
Revenue / Employee
382.12K
Employees
5,599
Market Cap
961.57M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.14B | 250.64M | 13.27% |
Dec 31, 2023 | 1.89B | 217.31M | 13.00% |
Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tchaikapharma High Quality Medicines AD | 53.14M |
Shelly Group SE | 208.70M |
Speedy AD | 519.17M |
First Investment Bank AD | 418.43M |
Eurohold Bulgaria AD | 2.79B |
M+S Hydraulic AD | 144.82M |
Smart Organic AD | 93.58M |
Bulgarian-American Credit Bank AD | 109.35M |